$CVSA

Phelan Robert J. sold $719K of CVSA

Phelan Robert J. (Chief Financial Officer) sold 5,314 shares of Covista Inc. (CVSA) at an average of $135.40 ($135.39–$135.41, $0.72M total) across 2 trades over 2026-07-07 to 2026-07-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Phelan Robert J.
Published Jul 9, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CVSA
Neutral
high confidence
Mentioned
$CVSA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CVSANeutralLow
01

Why it matters

The newest disclosed fact is the CFO’s open-market sale size, timing, and weighted-average price range, executed under a 10b5-1 plan.

02

Market read

Primarily a sentiment/positioning datapoint from insider activity; no new guidance, deal, or regulatory event is disclosed.

03

What to watch

Traders may want to compare this sale to prior insider transactions and the CFO’s remaining holdings to judge whether selling is sporadic or part of a broader pattern.

Relevance 4/10Novelty 3/10Timing: after-hours/filing update on 2026-07-09 for a 2026-07-07 to 2026-07-08 sale window

Background

The article is an SEC Form 4 insider transaction report for Covista Inc. (CVSA).

Company-level read

Ticker impact

$CVSANeutralHigh confidence
Context

Covista CFO Phelan Robert J. sold about $719.5K of CVSA shares via an open-market sale under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited, short-lived sentiment impact; more relevant for monitoring future insider activity than for fundamentals.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new company-specific news beyond the sale details.

Market effects

No clear sector read-through; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale was executed under a pre-arranged 10b5-1 plan, it may reflect liquidity planning rather than bearish expectations.

Key entities

  • Covista Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Phelan Robert J.

    Chief Financial Officer who sold CVSA shares.

  • 10b5-1 plan

    Pre-arranged plan cited as Yes, suggesting scheduled selling rather than discretionary timing.

Related articles

$CVSAMedAI 8/10

Covista (CVSA) Stock Trades Up, Here Is Why

Covista (NYSE: CVSA) shares rose about 13% after the company reported Q2 2026 revenue of $501.4 million, up 9.7% year over year, and adjusted EPS of $2.09, about 10% above Wall Street estimates. Operating margin increased to 19% from 16.8%. Covista also issued full-year adjusted earnings guidance above consensus; shares closed around $140.91.

$CVSAMedAI 8/10

Covista’s (NYSE:CVSA) Q2 CY2026 Sales Top Estimates

Covista (NYSE:CVSA), formerly DeVry Education Group, reported Q2 CY2026 revenue of $501.4 million, up 9.7% year on year and 3.1% above Wall Street estimates, according to the company. It guided full-year revenue to about $2.07 billion. Non-GAAP EPS was $2.09, 10.4% above consensus, and analysts expect full-year EPS to rise from $8.25 to $8.75.

$CVSAHigh

Covista Inc. (CVSA): Results of Operations and Financial Condition

Covista Inc. (CVSA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cvsa-20260806xex99d1.htm EX-99.1 Exhibit 99.1 Investor Contact: Jeremy Cohen Investor.Relations@Covista.com +1 312-906-6600 ​ Media Contact: Maureen Bender CovistaMedia@Covista.com +1 313-319-4732 Covista Announces Fiscal Year 2026 Results, Exceeds Financial Guidance; I